Bradley R Grant DO

Clinical Trials

• Sertraline Pediatric Registry for the Evaluation of Safety (SPRITES) Start of enrollment: 2012 Apr 04

  Completed

• A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD) Start of enrollment: 2011 Jun 01

  Completed

  Phase 2

• Lurasidone Pediatric Autism Study Start of enrollment: 2013 Aug 01

  Completed

  Phase 3

• Lurasidone Pediatric Bipolar Study Start of enrollment: 2014 Mar 01

  Completed

  Phase 3

• Study to Evaluate Safety & Efficacy of NaBen® as Add-on Treatment for Schizophrenia in Adults Start of enrollment: 2017 Mar 29

  Terminated

  Phase 2, Phase 3

• Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder (VLZ-MD-22) Start of enrollment: 2015 Feb 28

  Completed

  Phase 3

• Dasotraline Pediatric ADHD Study Start of enrollment: 2015 Apr 01

  Completed

  Phase 2, Phase 3

• Safety and Tolerability Study of SPD489 in Preschool Children Aged 4-5 Years, Diagnosed With Attention-deficit/Hyperactivity Disorder Start of enrollment: 2015 Aug 21

  Completed

  Phase 3

• Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 2) Start of enrollment: 2016 Feb 16

  Completed

  Phase 3

• Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD) Start of enrollment: 2016 May 01

  Completed

  Phase 3

• Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) Start of enrollment: 2016 Feb 02

  ACTIVE_NOT_RECRUITING

  PHASE3

• A Study to Investigate the Efficacy and Safety of Balovaptan (RO5285119) in Participants With Autism Spectrum Disorder (ASD) Start of enrollment: 2016 Nov 21

  Terminated

  Phase 2

• A Study of Balovaptan in Adults With Autism Spectrum Disorder With a 2-Year Open-Label Extension Start of enrollment: 2018 Aug 08

  Terminated

  Phase 3

• Long-term Antipsychotic Pediatric Safety Trial Start of enrollment: 2019 Jan 10

  COMPLETED

• Clinical Study Of caNNabidiol in childrEn and adolesCenTs With Fragile X (CONNECT-FX) Start of enrollment: 2018 Jun 12

  Completed

  Phase 2, Phase 3

• Software Treatment for Actively Reducing Severity of ADHD as Adjunctive Treatment to Stimulant Start of enrollment: 2018 Dec 28

  Completed

  Not Applicable

• A Study of OV101 in Individuals With Fragile X Syndrome Start of enrollment: 2018 Sep 17

  Completed

  Phase 2

• Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia Start of enrollment: 2019 Jun 06

  RECRUITING

  PHASE3

• A Study of Escitalopram in the Treatment of Children and Adolescents With Generalized Anxiety Disorder Start of enrollment: 2019 May 30

  Completed

  Phase 4

• Join now to see all